Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -0.01%271.16M | -0.36%1.42B | -1.47%904.05M | -3.58%571.41M | 7.15%271.18M | 5.23%1.42B | -1.31%917.55M | -4.39%592.64M | -8.83%253.08M | -13.47%1.35B |
Operating revenue | -0.01%271.16M | -0.36%1.42B | -1.47%904.05M | -3.58%571.41M | 7.15%271.18M | 5.23%1.42B | -1.31%917.55M | -4.39%592.64M | -8.83%253.08M | -13.47%1.35B |
Other operating revenue | ---- | 12.37%47.61M | ---- | 65.45%21.95M | ---- | 53.97%42.37M | ---- | 6.80%13.27M | ---- | -30.85%27.52M |
Total operating cost | 1.99%260.31M | 2.33%1.31B | 0.53%852.56M | -0.93%539.16M | 7.43%255.23M | 6.07%1.28B | -1.18%848.03M | -4.41%544.2M | -9.03%237.59M | -14.48%1.21B |
Operating cost | -0.89%183.84M | -1.70%984.08M | -5.17%616.76M | -6.69%386.95M | 4.33%185.49M | 5.56%1B | -2.03%650.38M | -5.54%414.69M | -9.74%177.78M | -15.44%948.4M |
Operating tax surcharges | -33.79%3.05M | 11.52%19.14M | 22.75%13.85M | 32.23%8.97M | 55.12%4.61M | 16.90%17.16M | 9.39%11.28M | 3.25%6.79M | -18.30%2.97M | -32.66%14.68M |
Operating expense | 19.16%38.84M | 13.93%161.07M | 13.53%111.77M | 13.19%71.83M | 18.59%32.6M | 22.74%141.38M | 14.63%98.45M | 15.37%63.46M | -1.18%27.49M | -9.97%115.18M |
Administration expense | 1.01%24.91M | 11.75%105.02M | 16.30%78.64M | 13.94%51.57M | 10.65%24.66M | -3.47%93.98M | -8.57%67.61M | -12.80%45.26M | -9.65%22.28M | -7.53%97.36M |
Financial expense | -557.46%-1.97M | -97.05%49.6K | 185.08%1.91M | 52.61%916.85K | -193.25%-299.01K | -46.82%1.68M | -15.48%671.38K | 232.90%600.8K | 221.33%320.64K | -5.83%3.16M |
-Interest expense (Financial expense) | -18.45%1.08M | 60.83%5.39M | 83.77%4.46M | 86.07%3.24M | 384.06%1.33M | -37.72%3.35M | -8.13%2.43M | 34.74%1.74M | -45.69%273.96K | 24.78%5.38M |
-Interest Income (Financial expense) | -266.13%-2.14M | -50.18%-2.3M | 24.57%-983.84K | 6.05%-832.76K | -48.41%-584.57K | -4.63%-1.53M | -77.13%-1.3M | -145.73%-886.38K | -98.88%-393.88K | -28.37%-1.46M |
Research and development | 42.25%11.64M | 56.69%43.67M | 50.90%29.64M | 41.12%18.92M | 21.32%8.19M | -9.88%27.87M | -16.13%19.64M | -19.58%13.4M | -15.66%6.75M | -10.73%30.93M |
Credit Impairment Loss | -148.98%-647.08K | -192.31%-15.94M | -3.63%-3.34M | -83.53%387.28K | -59.84%1.32M | 168.25%17.26M | 11.48%-3.22M | 171.61%2.35M | 384.57%3.29M | -153.25%-25.29M |
Asset Impairment Loss | 57.51%-1.22M | 3.17%-4.6M | -5.88%-4.89M | -37.14%-3.18M | -81.60%-2.87M | 32.85%-4.76M | 0.29%-4.61M | 45.61%-2.32M | -71.11%-1.58M | -8.49%-7.08M |
Other net revenue | -103.86%-75K | -62.81%11.07M | 181.95%15.39M | 79.95%16.51M | -63.29%1.94M | 682.78%29.76M | -52.29%5.46M | 0.49%9.17M | 156.12%5.29M | -235.47%-5.11M |
Fair value change income | ---- | 12.58%7.9M | 41.55%7.62M | 58.08%4.96M | 109.58%2.59M | 1,124.49%7.01M | 670.71%5.38M | 432.26%3.13M | 231.04%1.24M | -39.29%572.76K |
Invest income | 27.37%103.82K | -61.12%1.8M | -82.88%582.31K | -76.77%582.31K | -92.10%81.51K | -23.18%4.63M | -32.78%3.4M | -33.03%2.51M | -51.09%1.03M | 0.45%6.02M |
Asset deal income | 96.74%-6.7K | 5,735.63%2.56M | -344.92%-331.91K | -528.02%-317.1K | -446.24%-205.22K | 105.77%43.82K | 91.93%-74.6K | 81.14%-50.49K | -116.77%-37.57K | -907.45%-759.79K |
Other revenue | 66.32%1.69M | 247.44%19.36M | 243.36%15.74M | 296.31%14.09M | -24.34%1.02M | -74.01%5.57M | -72.24%4.58M | -74.88%3.55M | -55.09%1.34M | 61.73%21.43M |
Operating profit | -39.81%10.77M | -31.83%115.13M | -10.80%66.88M | -15.36%48.76M | -13.89%17.89M | 23.46%168.88M | -9.67%74.98M | -3.41%57.61M | 12.46%20.78M | -9.56%136.79M |
Add:Non operating Income | 71.66%126.31K | 435.75%740.18K | 103.49%670.2K | 75.14%348.46K | -19.40%73.58K | -90.79%138.16K | -70.84%329.35K | -82.07%198.96K | 289.48%91.29K | 141.14%1.5M |
Less:Non operating expense | 14.77%912.81K | 33.90%3.83M | -13.45%1.86M | 1.65%1.35M | 3.55%795.34K | 17.53%2.86M | 20.74%2.15M | 9.51%1.33M | 49.04%768.1K | -27.68%2.44M |
Total profit | -41.86%9.98M | -32.57%112.04M | -10.21%65.69M | -15.44%47.76M | -14.58%17.17M | 22.30%166.15M | -11.17%73.15M | -5.14%56.48M | 11.77%20.1M | -8.52%135.86M |
Less:Income tax cost | -42.82%2.21M | -41.62%21.71M | -8.65%14.86M | -29.34%9.37M | -31.58%3.86M | 41.37%37.18M | -13.76%16.27M | 4.40%13.26M | 19.90%5.64M | -19.59%26.3M |
Net profit | -41.58%7.78M | -29.96%90.33M | -10.65%50.82M | -11.18%38.39M | -7.96%13.31M | 17.72%128.97M | -10.39%56.88M | -7.73%43.22M | 8.90%14.46M | -5.39%109.56M |
Net profit from continuing operation | -41.58%7.78M | -29.96%90.33M | -10.65%50.82M | -11.18%38.39M | -7.96%13.31M | 17.72%128.97M | -10.39%56.88M | -7.73%43.22M | 8.90%14.46M | -5.39%109.56M |
Net profit of parent company owners | -41.58%7.78M | -29.96%90.33M | -10.65%50.82M | -11.18%38.39M | -7.96%13.31M | 17.72%128.97M | -10.39%56.88M | -7.73%43.22M | 8.90%14.46M | -5.39%109.56M |
Earning per share | ||||||||||
Basic earning per share | -41.67%0.0189 | -29.03%0.22 | -14.29%0.12 | -18.18%0.09 | -8.22%0.0324 | 14.81%0.31 | -6.67%0.14 | 0.00%0.11 | 17.67%0.0353 | -3.57%0.27 |
Diluted earning per share | -41.67%0.0189 | -29.03%0.22 | -14.29%0.12 | -18.18%0.09 | -8.22%0.0324 | 14.81%0.31 | -6.67%0.14 | 0.00%0.11 | 17.67%0.0353 | -3.57%0.27 |
Other composite income | 65.13%376.82K | -57.59%228.2K | 809.17%538.03K | |||||||
Other composite income of parent company owners | ---- | 65.13%376.82K | ---- | ---- | ---- | -57.59%228.2K | ---- | ---- | ---- | 809.17%538.03K |
Total composite income | -41.58%7.78M | -29.79%90.71M | -10.65%50.82M | -11.18%38.39M | -7.96%13.31M | 17.35%129.2M | -10.96%56.88M | -8.52%43.22M | 8.90%14.46M | -4.97%110.09M |
Total composite income of parent company owners | -41.58%7.78M | -29.79%90.71M | -10.65%50.82M | -11.18%38.39M | -7.96%13.31M | 17.35%129.2M | -10.96%56.88M | -8.52%43.22M | 8.90%14.46M | -4.97%110.09M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.